Publications by authors named "Tara N Kelley"
Purpose: The results of the 2022 American Society of Health-System Pharmacists (ASHP) Survey of Health-System Specialty Pharmacy (HSSP) Practice: Practice Models, Operations, and Workforce are presented.
Methods: A total of 273 leaders in HSSPs were contacted by email to complete a survey hosted using Qualtrics. The survey sample was compiled from ASHP member lists, the presence of a specialty pharmacy indicated in previous ASHP surveys, and outreach to ASHP member organizational leaders.
Integrated health-system specialty pharmacies (IHSSP) have shown high medication access, adherence, and provider satisfaction. The goal of this study was to explore healthcare providers' experiences with specialty medications distributed via Limited Distribution Networks (LDN) that do not include IHSSPs. We investigated healthcare providers' perceived impact of LDNs on clinic workflow, clinical practice, and patient outcomes.
View Article and Find Full Text PDFPurpose: Specialty medications can have life-altering outcomes for patients with complex diseases. However, their benefit relies on appropriate treatment selection, patients' ability to afford and initiate treatment, and ongoing treatment optimization based on patient response to therapy. Mounting research demonstrates the benefits of the health-system specialty pharmacies (HSSPs) in improving specialty medication access, affordability, and outcomes.
View Article and Find Full Text PDFPurpose: Health-system specialty pharmacies (HSSPs) provide high-quality, efficient, and collaborative care to patients receiving specialty therapy. Despite proven benefits of the integrated model, manufacturer and payer restrictions challenge the viability and utility of HSSPs. Vanderbilt Specialty Pharmacy developed a health outcomes and research program to measure and communicate the value of this model, drive improvement in patient care delivery, and advocate for recognition of HSSP pharmacists' role in patient care.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to evaluate the medication access rates for PCSK9 inhibitors in patients at a health care system with integrated specialty pharmacy services, focusing on those at high risk for cardiovascular issues.
- A total of 299 patients were studied, and the results showed that 96% of prescribed medications were accessible, with quick approval times and a majority receiving financial assistance.
- The findings suggest that using an integrated specialty pharmacy model in outpatient clinics enhances patient access to PCSK9 inhibitors, making it a recommended approach for managing such therapies.